594 / 1726
GUSTAVE ROUSSY
THÈME DU DIAPORAMA
RTOG-0724
Lead Group:
RTOG
SWOG
NSABP
NCIC
NCCTG
GOG
ECOG
CALGB
ACOSOG
POST-OP HIGH RISK CERVICAL
CANCERS:
Phase III Randomized Study of
Concurrent Chemotherapy and Pelvic RT
With or Without Adjuvant (Pacli + Carbo
every 21 days x 4 cycles) Chemotherapy in
High-Risk Patients with Early-Stage Cervical
Carcinoma Following Radical Hysterectomy
To Date:
163
Target:
400
(09/15/14)
GOG-0263
Lead Group:
GOG
SWOG
RTOG
NSABP
NCIC
NCCTG
ECOG
CALGB
ACOSOG
POST-OP INTERMEDIATE RISK CERVICAL
CANCERS:
Randomized Phase III Clinical
Trial of Adjuvant Radiation Versus Chemo-
radiation in Intermediate Risk, Stage I/IIA
Cervical Cancer Treated with Initial Radical
Hysterectomy and Pelvic LND dissection
Target:
534
Ongoing studies
Patients with clinical stage IA2, IB or IIA squamous,
adenosquamous, or adenocarcinoma of the cervix who have
any/all of the following high-risk f atures after surgery:
• Positive pelvic nodes
• Positive parametrium
• Positive para-aortic nodes- completely resected, PET/CT
negative (PET only required if positive para-aortic nodes
during surgery)